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Abstract
Background: Caenorhabditis elegans has emerged as a very powerful model for studying the host pathogen interactions.
Despite the absence of a naturally occurring viral infection for C. elegans, the model is now being exploited experimentally
to study the basic aspects of virus-host interplay. The data generated from recent studies suggests that the virus that infects
mammalian cells does infect, replicate and accumulate in C. elegans.
Methodology/Principal Findings: We took advantage of the easy-to-achieve protein introduction in C. elegans and
employing the methodology, we administered HIV-1 protein Nef into live worms. Nef is known to be an important protein
for exacerbating HIV-1 pathogenesis in host by enhancing viral replication. The deletion of nef from the viral genome has
been reported to inhibit its replication in the host, thereby leading to delayed pathogenesis. Our studies, employing Nef
introduction into C. elegans, led to creation of an in-vivo model that allowed us to study, whether or not, the protein induces
effect in the whole organism. We observed a marked lipodystrophy, effect on neuromuscular function, impaired fertility and
reduced longevity in the worms exposed to Nef. The observed effects resemble to those observed in Nef transgenic mice
and most interestingly the effects also relate to some of the pathogenic aspects exhibited by human AIDS patients.
Conclusions/Significance: Our studies underline the importance of this in vivo model for studying the interactions of Nef
with host proteins, which could further be used for identifying possible inhibitors of such interactions.
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Introduction
Human Immunodeficiency Virus -1 (HIV-1) Nef is accessory
protein, found early after HIV-1 infection in the cell, even before
the virus is integrated [1] and it regulates multiple functions in host
that enhance HIV-1 pathogenesis. The known functions that Nef
regulates are down regulation of the surface receptors CD4 [2]
and MHC-I [3], ability to modulate T cell signalling [4,5] and
anti-apoptosis [6].
All the stated functions are genetically separable from each
other and are regulated by Nef-host protein interaction. Nef
mediated MHC-I down regulation is initiated by interacting with
host PACS-2. The Nef/PACS-2 complex localize to trans-Golgi
network (TGN) where it binds to src family kinase (SFK). The
SFK would then bind and phosphorylate ZAP70/Syk on tyrosine
enabling ZAP70/Syk to bind the SH2 domain of phosphatidyli-
nositide 3-kinase (PI3K). The activated PI3K then leads to
elevated PIP3, stimulation of the guanine nucleotide exchange
factor ARNO, and GTP loading of ARF6. During the pathway,
the ternary complex of Nef engage with other proteins PACS-I,
AP1 and MHC-I for transit of MHC-I from the plasma membrane
to an internal compartment in a paranuclear region [7–11]. The
Nef induced CD4 downmodulation is mediated by a key
molecular heterotetrameric clathrin-associated adaptor protein 2
(AP2). For CD4 down regulation, the direct binding of NEF with
AP2 is with dileucine motif 160EXXXLL165 and two acidic
residues 174E/DD175 in Nef, which is found in a flexible loop
ranges from 148 to 180 amino acids. Mutations of either the
dileucines or the diacidic residues to alanines disables Nef binding
to AP2 in yeast three hybrid assay and inhibits CD4 down
regulation function [12,13]. Moreover, Colmen et al [14],
proposed an alternative pathway which is AP-2 independent
pathway and showed direct binding of Nef to the cytoplasmic tail
of CD4. The role of Nef in activating T cells is shown by
interacting with signalling proteins acting in the T cell recep-
tor(TCR) environment such as LCK, Vav, PAK and PKCh [4].
Their interaction could be possible in glycolipid–enriched
microdomain (lipid rafts) where Nef is found [15]. Nef forms
complex with Pak2 [16–19] and activates Pak 2 kinases [20,21].
An interaction domain that is responsible for Pak2 activation has
been observed to include residues 89 and 191 [22]. In myloid
lineage Nef activates myloid lineage specific tyrosine kinase HCK.
Nef tightly binds to the HCK SH3 domain in vitro and activates
its kinases activity [23]. The Nef/HCK interaction is mediated by
an SH3 binding domain in Nef 72PQVPLR77 which may be too
similar with cellular SH3 interaction. The role of Nef in anti-
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which links both the Fas- and the TNFR- mediated signals (by Fas
ligand and TNFa) to the downstream JNK/p38 pathway [6,24].
The overall Nef functions were vindicated in HIV-1 pathogen-
esis when Nef deleted HIV-1 infected patients showed delayed
progression towards Acquired Immuno Deficiency Syndrome
(AIDS) which had undetectable/low viral load with normal CD4
count [25,26]. In the experimental model, Nef deleted SIVmac 239
upon infection in rhesus monkey showed low viral load, normal
CD4 count and monkey lived healthy for long time [27]. These
studies suggested that Nef plays role in enhancing viral replication,
whether it has direct or indirect effect is not clearly understood. To
study the individual function of Nef, pertaining to HIV-1
replication, no feasible, laboratory model is present.
Interestingly, in mice model it was shown that among HIV
proteins, Nef harbours a major disease determinant and Nef
expressing in CD4+Tcells and macrophage/dendrite lineages
develop severe AIDS-like pathogenesis: failure to thrive/weight
loss, diarrhoea, wasting, premature death, thymus atrophy, loss of
CD4+ T cell, interstitial pneumonitis, and tubulo-interstitial
nephritis. Related to molecular function, Nef exhibit constitute
tyrosine phosphorylation of LAT and p42/44 MAP kinase and
anti-CD3 hyperactivity [28]. All the AIDS-like pathogenic effect in
mice is accrued possibly by the interaction of Nef-host protein
followed by activating pathways [29]. The Nef-host protein
interactions that are initiating pathways cannot be studied easily
in mice model because of the complexity of model and limitations
in scientific technologies, for example, genetic approaches of the
interaction in whole animal cannot be studied by RNA
interference (RNAi) techniques.
In recent years, model system Caenorhabditis elegans (C. elegans) has
been successfully employed for understanding numerous key
biological processes. Its appreciable homology of gene sequences
with those of humans, its conservation of many disease pathways
with higher vertebrates combined with its well studied develop-
mental biology and experimentally manipulable genetics, makes C.
elegans a precious model system for understanding intriguing
questions that relate to human health and disease [30]. In the past,
research studies exploiting the strengths of C. elegans have achieved
significant understanding of the disease conditions like Diabetes,
Obesity, Aging, Cancer, Neurodegenerative diseases, Ionchanne-
lopathies and Innate immunity related disorders [31]. Whereas the
transgenic, knockout or over-expressing disease models of C. elegans
have led researchers to identification of important pathways and/
or specific genetic targets, the basic research studies aimed at
understanding the biological processes have created a wealth of
knowledge that directly or indirectly leads to understanding
human disease conditions. C. elegans has also proved to be a very
powerful model for studying of host pathogen interactions. Despite
the absence of a naturally occurring viral infection for C. elegans,
the model is now being exploited experimentally to study the basic
aspects of virus-host interplay [32;33]. The data generated from
recent studies suggests that the virus that infects mammalian cells
does infect, replicate and accumulate in C. elegans. Using
transduction techniques of individual proteins, HIV protein Tat
has been shown to be successfully transduced within C. elegans [34]
In the present study we transduced viral Nef protein in C. elegans
and studied the presence and effect of Nef protein in whole animal.
Our result showed that transduced Nef protein was present in
entire tissues of animals and induced several altered physiological
effect in animals. These effects observed in C. elegans were
lipodystrophy, impaired locomotion, compromised reproductive
performance and reduced life span of nematodes. These
physiological effects in C. elegans are comparable with some
pathologic symptoms induced in Nef-transgenic (tg)-mice and in
HIV-1 patients.
Materials and Methods
C. elegans culture and maintenance
The studies were carried out in the wild type strain of C. elegans
(N2, var. Bristol), reared at 22uC on Nutrient Growth medium
(NGM) agar plates as described by Brenner [35]. The plates were
seeded either with ‘‘C41 strain of E.coli’’ (Control) or with ‘‘C41
strain of E.coli transfected with Nef’’ (Nef treated) as described in
next subsection. For analyses carried out on Day 8 of nematode
age, NGM was mixed with FUDR for restricting the growth of
progeny on the plates.
Treatment of nematodes with HIV-1 protein Nef
An inducible sequence of HIV-1 protein Nef was transfected
into the C41 strain of E. coli. The expression of Nef was induced by
adding Isopropyl b-D Galactopyranoside (IPTG) to the liquid
culture media at a concentration of 100 mM. The bacterial
cultures were plated onto the NGM plates, incubated overnight
(approx 18 hours) at 37uC. On the day of initiation of treatment,
gravid nematode populations were subjected to axenization for
isolation of embryos [36] so as to have a synchronous population
of nematodes. The isolated embryos were then transferred to
plates seeded either with E. coli strain C41 (control group) or with
E. coli strain C41 transfected with HIV-1 Nef sequence (Nef
treated group).
Immunohistochemistry using anti-Nef antibody
In order to confirm the absorption of Nef inside the system,
Immunohistochemistry of Nef treated nematodes was carried out
using an anti-Nef primary antibody and Alexa Fluor 488
secondary antibody. The method described in [37] was followed
with minor modifications. Briefly, the synchronous populations of
nematodes raised either on C41 or on Nef transfected C41, were
washed off the plates using M9 buffer. The adhering bacteria were
cleaned off by washing thrice with M9 buffer with brief
centrifugations at 100 g in between each washing. The washed
worms were fixed with 2.5% glutaraldehyde for 1 hour, freeze
fractured and permeabilized using Phosphate buffered saline with
Triton X-100 (PBST) overnight. The premeabilized worms were
then incubated in 1% BSA for one hour followed by subsequent
incubations in anti-Nef primary antibody at 1:100 dilution
(3 hours) and Alexa Fluor 488 (Invitrogen) secondary antibody
at 1:1000 dilution (for 1 hour). The worms were finally mounted
on slides using Prolong antifade mounting medium (Invitrogen),
sealed using DPX and analyzed for staining pattern under laser
scanning confocal microscope (Carl Zeiss).
Phenotypic analysis for studies on lipodystrophy
The phenotypic analysis of lipodystrophy induced by Nef was
carried out using stereozoom lab microscope. The thickness of Nef
treated worms was compared to that of control subjects. The
overall thickness of nematodes was quantified from still images, in
terms of total worm area using Image J software (Image J, National
Institutes of Health, Bethesda, MD).
Nile Red staining of lipid deposits in nematodes
The method described by Ashrafi et al [38] was followed. Briefly
the non-toxic lipid specific dye- Nile Red (Sigma), was mixed with
E.coli before seeding it onto the NGM plates/NGM-FUDR plates.
The synchronous aged embryos, derived from axenizing by
hypochlorite treatment, were transferred onto the seeded plates.
Effect of HIV-1 Nef on C. elegans
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48 hours and on NGM-FUDR plates for 8 days. At the
termination of treatment, nematodes were washed off the plates
using M9 buffer, cleared off any adhering bacteria by 2–3
washings and mounted in sodium azide/glycerol mixture, using
agar padded cover slip on a glass slide. The slides were sealed
using DPX mountant and analyzed using laser scanning confocal
microscope (Carl Zeiss). The still images were processed using
Image J software (Image J, National Institutes of Health, Bethesda,
MD) for quantification of florescence intensity.
Thrashing assay for effect on motility of nematodes
The thrashing assay of C. elegans is a well described method to
measure their motility. In this assay, control and treated worms
were washed off their parent plates using M9 buffer. The worms
were washed 2–3 times for getting rid of any adhering bacteria. A
drop of M9 buffer was placed on a clean glass slide. A single worm
was placed in the drop of buffer and allowed to stabilize for 30
seconds. The slide was placed under a stereozoom microscope, the
timer was set at 30 seconds and the frequency of sigmoidal body
bends was counted. One thrash was defined as complete bending
of the worm body one way to the outermost angle and back to the
initial posture. Thrashes were counted from 10 worms per
treatment condition.
Aldicarb assay for effect on excitatory neurotransmission
Aldicarb purchased from Supelco was stored as 1 M stock in
70% ethanol, at 4uC. NGM plates for the aldicarb assay were
prepared by adding aldicarb stock to the medium, prior to pouring
onto plates, so as to achieve a final concentration of 1 mM. The
assay plates were stored at 4uC and used within two weeks of
preparation. For carrying out the assays, the aldicarb assay plates
were bought to room temperature. The control or treated worms
were washed off their parent plates, cleared off the adhering
bacteria and transferred onto the aldicarb assay plates (30–40
worms per plate). The paralysis phenotype of worms was scored at
a fixed time point of 3 hours and compared to that of control
worms.
Assay for quantification of effect on reproductive
performance of nematodes
The effect of Nef on reproductive performance of C. elegans was
analyzed by rearing the synchronous populations of worms on
control or Nef transduced E. coli. At 48 hours of treatment, 10–20
worms were transferred from parent plates to fresh plates of the
same treatment condition. Worms were reared on the fresh plates
for another 24 hours. Experiments were carried out in triplicates
for each treatment condition and the total number of worms laid
on each plate per 24 hours was recorded to calculate the total
number of eggs laid per worm per 24 hours (fecundity), as a
measure of the reproductive performance of the nematodes. The
parent worms were removed from the plates and the progeny
arising from the eggs laid was analyzed the next day to quantify
the hatchability of laid eggs.
Life span assay
The effect of Nef on life span of nematodes was analyzed by
raising the worms on normal or Nef treated medium right from
the embryonic stage (embryos isolated as per [10]). The worms
were transferred to fresh plates everyday for first ten days and
every alternate day thereafter. This was done in order to prevent
mixing of two generations. The number of dead worms was
counted each day until the last worm was dead.
Statistical analysis
Statistical analysis was carried out using Sigma Stat software
package; calculation of statistical significance between various
groups was carried out employing Student’s t test.
Results
Trans-cellular introduction of HIV-1 protein Nef in C.
elegans
The feeding of worms on bacteria, transformed with an
inducible sequence of Nef, resulted in absorption of Nef via the
gut of nematodes. The Immunohistochemistry of nematodes
exposed to Nef for a period of 48 hours showed significant
presence of Nef in the worm. More than 90% of the Nef treated
nematodes exhibited a positive staining pattern with a variability
of less than 10%. Worms were imaged after probing with an anti-
Nef primary antibody and Alexa Fluor 488 (Molecular Probes)
secondary antibody Fig. 1 (a and d) show representative
fluorescence images of control and Nef treated nematodes
respectively. Figure 1b is Differential Interference Contrast
(DIC) image and Fig. 1c is merged image of Fig. 1a and b.
Similarly Fig. 1e and Fig. 1f are DIC and merged images for
Fig. 1d. Such transcellular introduction has been shown for
another HIV-1 protein, Tat, in C. elegans [34]. Previously, feeding
of C. elegans on bacterial strains expressing dsRNA sequences, has
been successfully employed to achieve systemic absorption of the
dsRNA, leading to RNAi mediated silencing of the target gene in
the nematode [38].
Nef induces severe lipodystrophy in C. elegans
One of the very striking observations made after the onset of
adulthood of nematodes, was that of severe lipodystrophy. More
than 85% of the worms raised on Nef loaded bacteria developed
into thin adults (Fig. 2b) as compared to their control counterparts
(Fig. 2a). The thickness of the worms, quantified in terms of ‘total
body area’ was found to be 12604.56254.5 pixels in control
worms, whereas Nef treated worms were found to have a total
body area of 4391.06739.0 pixels; thus exhibiting statistically
significant (p,0.05) reduction (Fig. 2c). The reduced thickness in
Nef treated worms was further confirmed to be as a result of
reduced lipid deposition, by staining the worms with lipid specific
dye nile red. Fig. 3a and 3c show representative images of the
Figure 1. Representative images for Immunohistochemical
staining of freeze-fractured C. elegans stained for the presence
of viral protein Nef on third day of treatment. a, b and c - Control,
d, e and f - Nef treated. Images a and d are fluorescent images, b and e
are images grabbed using Differential Interference Contrast (DIC) optics,
c and f are merged images of a,b and d,e respectively. Scale bar, 50 mm.
doi:10.1371/journal.pone.0015312.g001
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Figures 3b and 3d being the merged pictures for fluorescence and
DIC images of control and Nef treated groups respectively. The
staining intensity of Nef treated worms, as quantified by Image J
software, was found to be 4.1160.82 arbitrary units, which was
significantly (p,0.05) lower than that of control worms which
exhibited a fluorescence intensity of 12.1261.09 arbitrary units
(Fig. 3e). This observation of lipodystrophy is very much in
agreement with the effect of HIV pathogenesis in humans, as the
virus is known to induce multiple abnormalities including insulin
resistance, lipodystrophy and weight loss. This is because HIV
replication induces cellular enzymes and proteins that are
significantly associated with biologically relevant processes in-
volved in lipid synthesis, transport and metabolism.
Nef effects motility of worms by reducing excitatory
neurotransmission
Nematodes exposed to Nef for longer durations exhibited an
impaired gait and reduced locomotion. On an agar surface plated
with bacteria E. coli, worms were unable to express their typical
sinusoidal waves. We carried out thrashing assays of worms on day
3 and day 8 of the treatment. This was based on our phenotypic
analysis wherein we figured that effect of Nef is more pronounced
after at least 8 days of treatment. Thrashing in a drop of buffer,
was reduced in worms treated with Nef for 8 days as compared to
the control worms of same age (Fig. 4). Control worms exhibited a
thrashing count of 71 thrashes per 30 seconds, whereas the
thrashing count of Nef treated worms was 52 thrashes for the same
duration. Thus Nef treatment was observed to induce a statistically
significant (P,0.005) 27% reduction of thrashing in nematodes.
The behavioral pattern of lateral swimming or thrashing is
exhibited by nematodes while placed in any liquid. A healthy
worm thrashes continuously until exhausted of energy or until
moved back to a solid surface. However, if the neuromuscular
function of the nematode is compromised by exposure to any form
of stress, the effect reflects on the thrashing count too. In the
present experiment the Nef treatment seems to have affected the
neuromuscular function that resulted in the observed effect. To
further confirm the effect of Nef on neuromuscular function, we
carried out an assay employing Acetylcholine esterase (AChE)
inhibitor aldicarb. The exposure of healthy nematodes to aldicarb
results in reduced availability of AChE at the neuromuscular
junctions of worms, thereby leading to an increased accumulation
of neurotransmitter acetylcholine (ACh) at the neuromuscular
junction (NMJ), which in turn leads to paralysis of nematodes.
Depending upon increasing or decreasing the availability of ACh
at the NMJ, any chemical treatment or mutation, hastens or delays
the induction of this paralytic effect. In the present study, exposure
of nematodes to Nef for longer duration resulted in delaying of
aldicarb induced paralysis. The worms assayed for aldicarb
induced paralysis on Day 3 did not show a statistically significant
effect, whereas the worms assayed on day 8 of treatment showed a
59% resistance with respect to control worms (Fig. 5). In both the
conditions worms were raised on Nef right from the embryonic
stage.
The reproductive performance of C. elegans is impaired
by Nef
Each hermaphrodite nematode is known to lay approximately
300 eggs during its entire life span. In particular, egg laying starts
at the onset of adulthood and most number of eggs are laid during
the early half of the adult life of hermaphrodites. In the present
study, we observed a significant reduction of egg laying in Nef
treated worms when compared to their control counterparts
observed for their fecundity for a period of 24 hours starting at
48 hours of their age. The average number of eggs laid by worms
Figure 2. A representative phase contrast image of live worms
showing normal (a) and thin Nef treated nematodes (b) on day
8 of treatment. Scale bar, 100 mm. Fig. 2c is the graphical
representation of the ‘total body area’ of nematodes (*p,0.05).
doi:10.1371/journal.pone.0015312.g002
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treated worms was 43.262.4, thus Nef treated worms exhibiting a
30.2% reduction (P,0.005) in number of eggs laid in 24 hours
(Fig. 6). The laid embryos, however, did hatch normally and the
average percentage of hatched eggs was not statistically different
between control (82.260.6) and Nef treated (86.462.9) worms
(Fig. 7).
Nef induces early mortality in exposed C. elegans
populations
To study the effect of Nef on longevity, we raised the nematodes
on Nef loaded bacteria and observed effects on their life span as
Figure 3. Representative images for Nile red staining of Control (a,b) and Nef treated (c,d) worms (on day 8 of treatment) showing
the reduced amount of lipid deposits in Nef treated worms as compared to Control. (a) and (c) are fluorescence images, (b) and (d) are
merged images from DIC and fluorescent microscopy. Scale bar, 50 mm. Fig. 3e is graphical representation for fluorescence intensity of the
nematodes as quantified using Image J software (*p,0.05).
doi:10.1371/journal.pone.0015312.g003
Figure 4. Histogram showing effect of Nef on thrashing in C.
elegans; *p,0.005.
doi:10.1371/journal.pone.0015312.g004
Figure 5. Histogram showing effect of Nef on Aldicarb induced
paralysis; *p,0.005.
doi:10.1371/journal.pone.0015312.g005
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induced early mortality in the exposed population. On day 10 the
percentage mortality in control group was 11.262.5, whereas Nef
treated group exhibited a mortality percentage of 38.560.9 (Fig. 8).
The last mortality in control group occurred on day 17, whereas
all the worms of Nef treated group had died by 16
th day.
Significantly, another HIV protein Tat, was not shown to
induce any pathogenic effects in C. elegans [34]. Further our studies
with another protein, PACS1, transfected into C. elegans did not
induce any pathogenic response in the nematodes. This underlines
the fact that observed effects are caused specifically by Nef in the
treated nematodes.
Discussion
Our results show that Nef protein was successfully transduced
into the C. elegans system. The effects that Nef induced in the
nematode include; lipodystrophy, altered locomotion, compro-
mised reproductive performance and reduction of life span. These
effects, observed in C.elegans are well comparable with some
pathologic symptoms induced by Nef in transgenic mice and in
HIV-1 patients. Since, Nef does not have any enzymatic activity,
the functions scored by Nef are only by Nef-host protein
interaction [39]. Likewise, Nef-tg-mice showed AIDS like
pathogenesis and inhibition of CD4 downregulation which has
been attributed to the Nef-host protein interaction [40].
The worms treated with Nef protein developed into thin adults.
Staining of the Nef treated nematodes with lipid specific stain, Nile
Red, showed that lipid deposition in the Nef exposed population
was significantly reduced. Previously, body weight loss has been
reported in mice expressing Nef protein [40]. Presently, lipodys-
trophy in HIV-1 patient is extensively studied with the usage of
different anti-retro viral drugs (HAART) and the molecular
mechanisms affected in lipid metabolism during HAART regime
is studied [41]. However, the viral proteins involved in fat
metabolism were studied in mice [42] but their effect in human
patients is not studied pertaining to limitations. In recent years
significant efforts have been made to understand the basic
mechanism of fat accumulation in mammalian cells. The
molecular pathways and genes involved in regulating fat
metabolism are conserved between C.elegans and mammals [43]
For example, there is evidence to support the existence of
neuropeptide, serotonergic, and insulin signaling pathways that
regulate fat storage in both nematodes and mammals [44–46].
Specifically, deciphering the pathways and genes affected by Nef
in C.elegans may be helpful to understand the molecular pathways
regulating HIV lipodystrophy which is characterized by hypertri-
Figure 6. Histogram showing effect of Nef on fecundity of C.
elegans;* p ,0.005.
doi:10.1371/journal.pone.0015312.g006
Figure 7. Histogram showing effect of Nef on hatchability of
eggs in C. elegans.
doi:10.1371/journal.pone.0015312.g007
Figure 8. Line graph showing effect of Nef on the life span of C.
elegans.
doi:10.1371/journal.pone.0015312.g008
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resistance, altered energy expenditure and lipomatosis [47].
In our studies Nef was observed to effect normal locomotory
behavior as evidenced by reduced thrashing of treated worms. The
overall phenotypic analysis and the severe effect on thrashing
pointed towards effect of Nef on excitatory neurotransmission. To
understand this, we carried out a pharmacological assay
employing an Acetylcholine Esterase (AChE) inhibitor aldicarb.
Our observation of increased resistance to paralysis in case of
worms treated with Nef made us believe that the viral protein
affects the availability of excitatory neurotransmitter Acetyl
Choline (ACh) at the synapse. This could be either because of
reduced synthesis of the neurotransmitter ACh or because of its
increased breakdown before its reaching the synapse. The
indication of such an effect of Nef on the availability of ACh
may give us lead to understand and identify the molecular
mechanism of Nef induced effect on ACh-AChE pathway, as
previous reports have also shown AChE mediated CD4+T cell
activation in response to HIV infection [48].
In our studies the effect of Nef was also observed on the
reproduction of C.elegans; an effect not reported previously in other
model systems probably because other effects of the viral protein,
including effect on longevity, are so pronounced that the effect on
reproduction cannot be studied. Model system C. elegans made it
easy to study the effect as it attains sexual maturity early on, even
before other effects are well pronounced. Our studies show that
Nef significantly reduces fecundity of the exposed nematodes;
though the laid embryos do hatch normally, but the overall brood
size of the exposed population was significantly reduced as a result
of Nef exposure. Previously various chemical effects have been
reported to affect C. elegans reproduction as a result of their toxic
effects [49, 50]. In the current study, Nef might also be inducing
deleterious effects on the pathways that control the nematode
reproduction. Interestingly a recent report has also reported role of
a common factor, Klf-3, in altering lipid deposition and affecting
reproduction of C. elegans [51]. It could very well be possible that a
similar effect is being induced by Nef that is altering the
downstream signaling pathways leading to the observed pheno-
types.
C. elegans is a well studied model for ageing; studies on protein
interaction networks have shown conservation of ageing process
between humans and other invertebrate species including C. elegans
[52]. The overall pathological effect of Nef observed in the present
studyhascumulativeeffectondecreasingthelifespanofnematodes.
Most notably, this effect in the present study was observed in the
absence of any confounding factors like opportunistic infections
that, otherwise, are known to induce early mortality in case of HIV
patients. In the present study, the effect of Nef on life span indicates
that this critical viral protein per se does induce adverse effects as
drastic as reducing longevity of the exposed organism. Similarly in
mice, Nef transgenic mice lines, have reduced life span compared to
control [40]. These observations, from model system C. elegans,
make it tempting to speculate that the presence of Nef not only
enhances the viral replication thereby increasing the viral load in
host, but also contributes towards an increased pathogenesis leading
to multiple pathological effects. Thismodel will be immensely useful
towards identifying specific host-pathogen, protein-protein interac-
tions and towards further deciphering of molecular mechanisms of
Nef pathogenesis in HIV-1 infected patients. The model would
further be useful towards screening of specific inhibitors as also
suggested previously via virtual screening of first set of possible
inhibitors [53].
Our studies lead towards creation of an in vivo environment, in
the genetically relevant and experimentally accessible model
system C. elegans which would be of immense importance for
studying the interactions of Nef with host proteins and would
further be used for identifying possible inhibitors of such
interactions.
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